# A Proof of Concept Study to Evaluate the Effect of UB-421 in Combination With Chidamide on HIV Viral Reservoir

> **NCT04985890** · PHASE2 · NOT_YET_RECRUITING · sponsor: **UBP Greater China (Shanghai) Co., Ltd** · enrollment: 20 (estimated)

## Conditions studied

- HIV-1-infection

## Interventions

- **BIOLOGICAL:** UB-421
- **OTHER:** UB-421+chidamide

## Key facts

- **NCT ID:** NCT04985890
- **Lead sponsor:** UBP Greater China (Shanghai) Co., Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-03
- **Primary completion:** 2026-12
- **Final completion:** 2027-12
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2023-05-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04985890

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04985890, "A Proof of Concept Study to Evaluate the Effect of UB-421 in Combination With Chidamide on HIV Viral Reservoir". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04985890. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*